Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
Endocrine Connections · 01.05.2025 · 14 (5)
DOI: 10.1530/ec-24-0529 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Connections, online erschienen am 11.03.2025. Verfasst von Marine Monney und 3 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. This condition is associated with various hormonal, reproductive and metabolic alterations, including androgen excess, ovulatory disorders and a hyperinsulinemic state. A personalized therapeutic approach is necessary to improve PCOS, focusing on patients’ main concerns, with the goal of addressing ovarian dysfunction, reducing hyperandrogenism and improving metabolic alterations, particularly through weight reduction. The therapeutic class of glucagon-like peptide-1 receptor analogues (GLP-1 RAs) represents an attractive option for PCOS due to its various beneficial effects, such as weight loss. In this review, we discuss the clinical and pathological aspects of PCOS, as well as the data and potential roles of GLP-1 RAs in managing this condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
ORCID-Profile: Marine Monney
Zitieren
APA
Monney, M., Mavromati, M., Leboulleux, S., & Gariani, K. (2025). Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review. Endocrine Connections, 14(5). https://doi.org/10.1530/ec-24-0529
Vancouver
Monney M, Mavromati M, Leboulleux S, Gariani K. Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review. Endocrine Connections. 2025;14(5). doi:10.1530/ec-24-0529
BibTeX
@article{Monney2025,
author = {Monney, Marine and Mavromati, Maria and Leboulleux, Sophie and Gariani, Karim},
title = {Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review},
journal = {Endocrine Connections},
year = {2025},
volume = {14},
number = {5},
doi = {10.1530/ec-24-0529}
}
EUVIMED